Azenta Inc (AZTA)
41.61
-0.82
(-1.93%)
USD |
NASDAQ |
Mar 28, 16:00
41.61
0.00 (0.00%)
After-Hours: 20:00
Key Stats
| Price and Performance | |
|---|---|
| Market Cap | 2.875B |
| 52 Week High (Daily) | Upgrade |
| 52 Week Low (Daily) | Upgrade |
| All-Time High (Daily) | Upgrade |
| Year to Date Total Returns (Daily) | Upgrade |
| 1 Month Total Returns (Daily) | Upgrade |
| 1 Year Total Returns (Daily) | -50.26% |
| Valuation | |
| PE Ratio | 1.501 |
| PE Ratio (Forward) | Upgrade |
| PS Ratio | 5.207 |
| Price to Book Value | 1.001 |
| EV to EBITDA | Upgrade |
| Dividend | |
|---|---|
| Dividend | -- |
| Dividend Yield (Forward) | Upgrade |
| Financials | |
| Revenue (5 Year Growth) | Upgrade |
| Revenue (Quarterly YoY Growth) | Upgrade |
| EPS Diluted (5 Year Growth) | Upgrade |
| EPS Diluted (Quarterly YoY Growth) | Upgrade |
| Debt to Equity Ratio | 0.00 |
| Return on Equity | Upgrade |
| Return on Assets | Upgrade |
| Risk | |
| Beta (5Y) | Upgrade |
| Max Drawdown (5Y) | 68.88% |
News
Headline
Wire
Time (ET)
PR Newswire
03/15 17:06
Yahoo
02/27 07:30
PR Newswire
02/10 07:30
MT Newswires
02/09 09:19
MT Newswires
02/09 07:56
Events
| DATE | TIME | TYPE | PERIOD | REPORTED EPS |
ESTIMATED EPS |
SURPRISE | |
| 05/09/2023* | -- | Results | Q2 2023 | -- | -0.03 | -- | |
| 05/09/2023* | 16:30 EST | Earnings Call | Q2 2023 | -- | -- | -- | |
| 02/08/2023 | -- | Results | Q1 2023 | 0.12 | 0.10 | 20.00% | |
| 02/08/2023 | 16:30 EST | Earnings Call | Q1 2023 | -- | -- | -- | |
| 11/14/2022 | -- | Results | Q4 2022 | 0.16 | 0.07 | 142.4% | |
| 11/14/2022 | 16:30 EST | Earnings Call | Q4 2022 | -- | -- | -- | |
| 08/09/2022 | -- | Results | Q3 2022 | 0.12 | 0.09 | 37.14% | |
| 08/09/2022 | 16:30 EST | Earnings Call | Q3 2022 | -- | -- | -- |
*Estimated Date/Time
Earnings
Profile
Edit
| Azenta Inc is a provider of life sciences solutions worldwide, enabling impactful breakthroughs and therapies to market faster. It provides a full suite of reliable cold-chain sample management solutions and genomic services across areas such as drug development, clinical research and advanced cell therapies for the industry's top pharmaceutical, biotech, academic and healthcare institutions globally. |
| URL | https://www.azenta.com |
| Investor Relations URL | https://investors.azenta.com/ |
| HQ State/Province | Massachusetts |
| Sector | Healthcare |
| Industry | Medical Instruments & Supplies |
| Equity Style | Small Cap/Growth |
| Next Earnings Release | May. 09, 2023 (est.) |
| Last Earnings Release | Feb. 08, 2023 |
| Next Ex-Dividend Date | N/A |
| Last Ex-Dividend Date | Dec. 02, 2021 |
Analyst Coverage
|
Consensus Rating
|
|
|
Analyst Recommendation
|
|
Source: S&P Global
Dividends
| Dividend Per Share (TTM) | 0.00 |
|
2017
2018
2019
2020
2021
6.00%
4.00%
2.00%
|
|
| Yield to Market | 0.00 |
| Yield to Sector | 0.00 |
| Yield to Industry | 0.00 |
| Last Dividend Amt. | -- |
| Dividend Frequency | Quarterly |
| Last Ex-Dividend Date | Dec. 02, 2021 |
| Yield (TTM) | 0% |
| Forward Yield | -- |
| Payout Ratio | 0.00% |
| Cash Payout Ratio | 0.00% |
| Consistent Payer (5Y) | No |
| Consistent Growth (5Y) | No |
Risk
Total Returns Comparison
Annual Total Returns Versus Peers
As of March 27, 2023.
Fundamentals
| Revenue (TTM) | 594.21M |
| Total Expenses (TTM) | 644.30M |
| Net Income (TTM) | 2.078B |
| Total Assets (Quarterly) | 3.292B |
| Total Liabilities (Quarterly) | 421.03M |
| Shareholders Equity (Quarterly) | 2.871B |
| Cash from Operations (TTM) | -508.68M |
| Cash from Investing (TTM) | 1.540B |
| Cash from Financing (TTM) | -559.80M |
Ratings
Profile
Edit
| Azenta Inc is a provider of life sciences solutions worldwide, enabling impactful breakthroughs and therapies to market faster. It provides a full suite of reliable cold-chain sample management solutions and genomic services across areas such as drug development, clinical research and advanced cell therapies for the industry's top pharmaceutical, biotech, academic and healthcare institutions globally. |
| URL | https://www.azenta.com |
| Investor Relations URL | https://investors.azenta.com/ |
| HQ State/Province | Massachusetts |
| Sector | Healthcare |
| Industry | Medical Instruments & Supplies |
| Equity Style | Small Cap/Growth |
| Next Earnings Release | May. 09, 2023 (est.) |
| Last Earnings Release | Feb. 08, 2023 |
| Next Ex-Dividend Date | N/A |
| Last Ex-Dividend Date | Dec. 02, 2021 |
Ownership
| Insider Ownership Percentage | Upgrade |
Jul '20
Nov '20
Mar '21
80.00%
40.00%
10.00%
Analyst Coverage
|
Consensus Rating
|
|
|
Analyst Recommendation
|
|
Source: S&P Global
Top Fund Holders
Other Resources
| Whale Wisdom | 13F Filings |
| Seeking Alpha | Call Transcripts |
| Nasdaq | Insider Trading |
| Nasdaq | Institutional Ownership |
| Nasdaq | Option Chain |
| SEC | SEC Filings |
| AZTA Tweets |